Logo-jcvtr

J Cardiovasc Thorac Res. 2021;13(4): 314-319. doi: 10.34172/jcvtr.2021.51
PMID: 35047136        PMCID: PMC8749358

Original Article

Effects of sodium selenite and selenium-enriched yeast on cardiometabolic indices of patients with atherosclerosis: A double-blind randomized clinical trial study

Mahdiyeh Khabbaz Koche Ghazi 1 ORCID, Samad Ghaffari 2, Mohammad Naemi 1, Rezvaniyeh Salehi 2, Mohammadreza Taban Sadeghi 2, Meisam Barati 3, Alireza Namazi Shabestari 4, Behnam Kafil 1, Naimeh Mesri Alamdari 5,6, Hamid Soleimanzadeh 7, Ali Tarighat-Esfanjani 1 * ORCID, Neda Roshanravan 2 * ORCID

Cited by CrossRef: 3


1- Dabravolski S, Sukhorukov V, Melnichenko A, Khotina V, Orekhov A. The Role of Selenium in Atherosclerosis Development, Progression, Prevention and Treatment. Biomedicines. 2023;11(7):2010 [Crossref]
2- Ouyang J, Cai Y, Song Y, Gao Z, Bai R, Wang A. Potential Benefits of Selenium Supplementation in Reducing Insulin Resistance in Patients with Cardiometabolic Diseases: A Systematic Review and Meta-Analysis. Nutrients. 2022;14(22):4933 [Crossref]
3- Vajdi M, Hassanizadeh S, Gholami Z, Bagherniya M. Selenium supplementation effect on glycemic control: A GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials. Pharmacological Research. 2023;195:106888 [Crossref]